Meanwhile, tumor-bearing mice also showed good safety and tolerability to continuous administration of plant-produced anti-CTLA-4 antibody since no apparent body weight loss (>10%) were observed throughout the experiment (Figure 6D). This evidence concerns the gene CTLA4 and neoplasm.